Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Spotlight Growth

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Kintara Therapeutics (NASDAQ: KTRA) Granted Orphan Drug Status for VAL-083 and the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
Via Spotlight Growth
Exposures Product Safety
Tickers KTRA
Vision Marine Technologies (NASDAQ: VMAR) Receives Initial E-Motion Propulsion System Purchase Order from Groupe Beneteau
Via Spotlight Growth
Topics Supply Chain
Exposures Supply Chain
Tickers VMAR
HeartBeam (NASDAQ: BEAT) Stands to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product
Via Spotlight Growth
Tickers AAPL BEAT IRTC
Avidity Biosciences (NASDAQ: RNA) Posts Positive Phase 1/2 MARINA Data on AOC 1001, Announcing the First Successful Delivery of RNA to Muscle
Via Spotlight Growth
Tickers RNA
OpGen (NASDAQ: OPGN) Reports Positive Data from Clinical Trial for Unyvero as Diagnostic for UTI
Via Spotlight Growth
Tickers OPGN
Vision Marine’s (NASDAQ: VMAR) E-Motion™ Electric Propulsion System to be Rolled Out Across Groupe Beneteau Brand Portfolio Per Strategic Master Supplier Agreement
Via Spotlight Growth
Topics Supply Chain
Exposures Supply Chain
Tickers VMAR
Yuengling’s Ice Cream Corporation (OTC Pink: YCRM) Enters Into Exclusive Licensing Agreement with GPO Plus (OTCQB: GPOX) to Create CBD & Cannabinoid Ice Cream
Via Spotlight Growth
Tickers GPOX YCRM
Harpoon Therapeutics (NASDAQ: HARP) Releases Updated Phase 1 Interim Results for HPN217 in Treating Relapsed Multiple Myeloma
Via Spotlight Growth
Tickers HARP
Baudax Bio (NASDAQ: BXRX) Launches Phase 2 Clinical Trial Testing BX1000 for Neuromuscular Blockade in Patients Undergoing Surgery
Via Spotlight Growth
Tickers BXRX
Rent the Runway (NASDAQ: RENT) Reports Record Quarterly Revenue of $77.4 Million, Raises Annual Revenue and Adj. EBITDA Guidance
Via Spotlight Growth
Tickers NFLX RENT
HeartBeam (NASDAQ: BEAT): Innovative Technologies Disrupting the Old Standard of Care for Heart Patients and Upgrading ECG for the 21st Century
Via Spotlight Growth
Topics Death
Exposures Death
Tickers BEAT
Prometheus Biosciences (NASDAQ: RXDX) Reports PRA023 Candidate Achieved Positive Results in Both its ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Clinical Trials
Via Spotlight Growth
Tickers RXDX
HeartBeam (NASDAQ: BEAT) Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device
Via Spotlight Growth
Topics Supply Chain
Exposures Product Safety Supply Chain
Tickers BEAT
Vivint Smart Home (NYSE: VVNT) Enters into Agreement to be Acquired by NRG Energy (NYSE: NRG) for $2.8 Billion
Via Spotlight Growth
Topics Energy
Exposures Fossil Fuels
Tickers NRG VVNT
Anavex Life Sciences (NASDAQ: AVXL) Says Phase 2b/3 for ANAVEX2-73 Met Primary and Secondary Endpoints Reducing Cognative Decline in Patients with Early Alzheimer’s
Via Spotlight Growth
Exposures Product Safety
Tickers AVXL
XPeng (NYSE: XPEV) Reports Revenue Growth of 19.3% During Third Quarter 2022, But Q4 Outlook Warns of Sharp Decrease in Deliveries
Via Spotlight Growth
Topics Electric Vehicles
Exposures Electric Vehicles
Tickers XPEV
Analysts Reiterate Bullish Stance on Asure Software (NASDAQ: ASUR), Collectively Raise Target Price to Average of $11.00
Via Spotlight Growth
Topics Stocks
Exposures US Equities
Tickers AAPL AMZN ASUR EFX
Apollo Endosurgery (NASDAQ: APEN) Enters Into Agreement to be Acquired by Boston Scientific (NYSE: BSX) for $615 Million
Via Spotlight Growth
Exposures Product Safety
Tickers APEN BSX
Taboola (NASDAQ: TBLA) Signs 30-Year Advertising Collaboration Agreement with Yahoo
Via Spotlight Growth
Tickers TBLA VZ
Palisade Bio (NASDAQ: PALI) Awarded Fast Track Designation from U.S. FDA for LB1148
Via Spotlight Growth
Exposures Product Safety
Tickers PALI
Imago BioSciences (NASDAQ: IMGO) to be Acquired by Merck (NYSE: MRK) for $1.35 Billion
Via Spotlight Growth
Tickers IMGO MRK
CytomX Therapeutics (NASDAQ: CTMX) and Regeneron (NASDAQ: REGN) Enter into Strategic Collaboration to Develop Bispecific Therapies to Treat Cancer
Via Spotlight Growth
Tickers CTMX REGN
InMed Pharmaceuticals (NASDAQ: INM) Says Research Grant to Test Cannabinoid Analogs as a Potential Treatment for Alzheimer’s, Parkinson’s and Huntington’s Disease
Via Spotlight Growth
Tickers INM
Asure (NASDAQ: ASUR) Reports Strong Q3 2022 Earnings – Management Upbeat with Encouraging Top & Bottom Lines
Via Spotlight Growth
Topics Economy
Exposures Economy Interest Rates
Tickers ASUR EFX
Sea Limited’s (NYSE: SE) E-Commerce and Digital Services Business Drives Q3 Earnings Growth
Via Spotlight Growth
Tickers SE
Pineapple Energy (NASDAQ: PEGY) Reports Third Quarter Results Showing Over 100% Growth in Sold Kilowatts and Battery Capacity
Via Spotlight Growth
Tickers PEGY
Opiant Pharmaceuticals (NASDAQ: OPNT) Enters Into Definitive Agreement to be Acquired by Indivior for $145 Million
Via Spotlight Growth
Tickers OPNT
Sono Motors (NASDAQ: SEV) Inks Collaboration Deal with Bosch for Europe-Wide Auto Servicing and Repair
Via Spotlight Growth
Topics Electric Vehicles
Exposures Electric Vehicles
Tickers SEV
Ebix (NASDAQ: EBIX) Reports Strong Q3 2022 Financial Results Showing 35% Y/Y Growth in Revenue Despite Forex Challenges
Via Spotlight Growth
Exposures COVID-19
Tickers EBIX
Outset Medical (NASDAQ: OM) Releases Third Quarter 2022 Financial Results Showing Modest Revenue Growth Y/Y
Via Spotlight Growth
Tickers OM
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.